Chase Knickerbocker
Stock Analyst at Craig-Hallum
(4.84)
# 81
Out of 5,239 analysts
46
Total ratings
70.59%
Success rate
44.68%
Average return
Main Sectors:
Stocks Rated by Chase Knickerbocker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXG MiMedx Group | Maintains: Buy | $10 → $7 | $3.52 | +98.86% | 3 | Apr 17, 2026 | |
| ACOG Alpha Cognition | Initiates: Buy | $14 | $5.95 | +135.30% | 1 | Apr 17, 2026 | |
| NRXS NeurAxis | Maintains: Buy | $8 → $13 | $7.91 | +64.35% | 3 | Mar 20, 2026 | |
| ETON Eton Pharmaceuticals | Maintains: Buy | $30 → $35 | $30.82 | +13.56% | 8 | Mar 20, 2026 | |
| HROW Harrow | Maintains: Buy | $54 → $64 | $29.83 | +114.59% | 4 | Sep 23, 2025 | |
| FENC Fennec Pharmaceuticals | Maintains: Buy | $13 → $14 | $6.77 | +106.79% | 6 | Aug 15, 2025 | |
| PYPD PolyPid | Maintains: Buy | $15 → $13 | $4.22 | +208.06% | 2 | Aug 14, 2025 | |
| XERS Xeris Biopharma Holdings | Maintains: Buy | $6.5 → $11 | $6.43 | +71.07% | 2 | Aug 8, 2025 | |
| DMAC DiaMedica Therapeutics | Maintains: Buy | $8 → $11 | $6.26 | +75.72% | 1 | Jul 18, 2025 | |
| BFLY Butterfly Network | Initiates: Buy | $3 | $3.92 | -23.47% | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $17 | $12.56 | +35.35% | 3 | Jun 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $39 | $16.25 | +140.00% | 1 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $3.68 | +117.39% | 4 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $21 | $11.61 | +80.88% | 2 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $6 | $3.85 | +55.84% | 2 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $9.27 | +7.87% | 1 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1 → $1.2 | $0.48 | +150.00% | 2 | Jul 11, 2023 |
MiMedx Group
Apr 17, 2026
Maintains: Buy
Price Target: $10 → $7
Current: $3.52
Upside: +98.86%
Alpha Cognition
Apr 17, 2026
Initiates: Buy
Price Target: $14
Current: $5.95
Upside: +135.30%
NeurAxis
Mar 20, 2026
Maintains: Buy
Price Target: $8 → $13
Current: $7.91
Upside: +64.35%
Eton Pharmaceuticals
Mar 20, 2026
Maintains: Buy
Price Target: $30 → $35
Current: $30.82
Upside: +13.56%
Harrow
Sep 23, 2025
Maintains: Buy
Price Target: $54 → $64
Current: $29.83
Upside: +114.59%
Fennec Pharmaceuticals
Aug 15, 2025
Maintains: Buy
Price Target: $13 → $14
Current: $6.77
Upside: +106.79%
PolyPid
Aug 14, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $4.22
Upside: +208.06%
Xeris Biopharma Holdings
Aug 8, 2025
Maintains: Buy
Price Target: $6.5 → $11
Current: $6.43
Upside: +71.07%
DiaMedica Therapeutics
Jul 18, 2025
Maintains: Buy
Price Target: $8 → $11
Current: $6.26
Upside: +75.72%
Butterfly Network
Jul 1, 2025
Initiates: Buy
Price Target: $3
Current: $3.92
Upside: -23.47%
Jun 9, 2025
Maintains: Buy
Price Target: $12 → $17
Current: $12.56
Upside: +35.35%
Feb 28, 2025
Initiates: Buy
Price Target: $39
Current: $16.25
Upside: +140.00%
Jan 22, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $3.68
Upside: +117.39%
Jan 17, 2025
Maintains: Buy
Price Target: $18 → $21
Current: $11.61
Upside: +80.88%
Jan 17, 2025
Maintains: Buy
Price Target: $5 → $6
Current: $3.85
Upside: +55.84%
Jul 11, 2024
Initiates: Buy
Price Target: $10
Current: $9.27
Upside: +7.87%
Jul 11, 2023
Maintains: Buy
Price Target: $1 → $1.2
Current: $0.48
Upside: +150.00%